Stockscreener 앱 받기
70.87
1.42%
0.99
전일 마감가:
$69.88
열려 있는:
$70.07
하루 거래량:
1.94M
Relative Volume:
0.88
시가총액:
$13.70B
수익:
$29.52M
순이익/손실:
$-567.06M
주가수익비율:
-19.36
EPS:
-3.66
순현금흐름:
$-551.11M
1주 성능:
+4.61%
1개월 성능:
+32.49%
6개월 성능:
+82.94%
1년 성능:
+24.82%
1일 변동 폭
$69.50
$71.97
1주일 범위
$67.27
$72.72
52주 변동 폭
$29.17
$72.72
Revolution Medicines Inc Stock (RVMD) Company Profile
명칭
Revolution Medicines Inc
전화
415-766-3638
주소
700 SAGINAW DR, REDWOOD CITY, CA
RVMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
70.87 | 13.51B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | Wolfe Research | Outperform |
| 2025-11-03 | 개시 | RBC Capital Mkts | Outperform |
| 2025-10-21 | 개시 | Mizuho | Outperform |
| 2025-10-16 | 재개 | Stifel | Buy |
| 2025-09-12 | 재개 | Raymond James | Strong Buy |
| 2025-09-05 | 개시 | Truist | Buy |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-08-15 | 개시 | Wells Fargo | Overweight |
| 2025-07-15 | 개시 | Goldman | Buy |
| 2024-07-16 | 재확인 | Needham | Buy |
| 2024-07-12 | 개시 | Barclays | Overweight |
| 2024-07-08 | 개시 | Jefferies | Buy |
| 2024-04-12 | 재확인 | Needham | Buy |
| 2024-04-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-11 | 개시 | Piper Sandler | Overweight |
| 2024-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-01-04 | 개시 | Wedbush | Outperform |
| 2023-11-16 | 개시 | Raymond James | Outperform |
| 2023-02-28 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-12-14 | 개시 | Needham | Buy |
| 2022-10-21 | 개시 | Oppenheimer | Outperform |
| 2022-05-20 | 개시 | BofA Securities | Neutral |
| 2022-03-01 | 업그레이드 | Stifel | Hold → Buy |
| 2021-09-23 | 개시 | Stifel | Hold |
| 2021-08-12 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-05-18 | 개시 | Goldman | Buy |
| 2020-05-21 | 개시 | H.C. Wainwright | Buy |
| 2020-03-09 | 개시 | Cowen | Outperform |
| 2020-03-09 | 개시 | Guggenheim | Buy |
| 2020-03-09 | 개시 | JP Morgan | Neutral |
모두보기
Revolution Medicines Inc 주식(RVMD)의 최신 뉴스
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Is Revolution Medicines Inc Equity Warrant a good long term investmentVolatility Adjusted Trading & Free Short-Term Trading Strategies - earlytimes.in
Westfield Capital Management Co. LP Increases Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Neo Ivy Capital Management Invests $1.14 Million in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by Geode Capital Management LLC - MarketBeat
Revolution Medicines gets FDA Breakthrough Therapy status for daraxonrasib - MSN
Revolution Medicines IncOrdinary Shares (RVMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mark Goldsmith Sells 20,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Upgraded at Wolfe Research - MarketBeat
Revolution Medicines Reports Q3 2025 Financial Results - MSN
Why Revolution Medicines Inc. (42Z) stock could rally strongly2025 EndofYear Setup & Technical Confirmation Alerts - newser.com
Market reaction to Revolution Medicines Inc. Equity Warrant’s recent newsQuarterly Profit Report & Weekly High Conviction Ideas - newser.com
[Form 4] Revolution Medicines, Inc. Insider Trading Activity - Stock Titan
Revolution Medicines Insider Sold Shares Worth $939,008, According to a Recent SEC Filing - MarketScreener
Revolution Medicines Insider Sold Shares Worth $1,407,586, According to a Recent SEC Filing - MarketScreener
Executives at Revolution Medicines Conduct Stock Transactions - TradingView
Officer Cislini Sells 13,388 ($939K) Of Revolution Medicines Inc [RVMD] - TradingView
Police & Firemen s Retirement System of New Jersey Boosts Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Can Revolution Medicines Inc. Equity Warrant stock withstand economic slowdownTrade Volume Report & High Conviction Trade Alerts - newser.com
Catalyst Funds Management Pty Ltd Takes Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Will Revolution Medicines Inc. (42Z) stock boost dividends further2025 Market Trends & Fast Entry Momentum Trade Alerts - newser.com
Why Revolution Medicines Inc. Equity Warrant stock remains a top recommendationMarket Movers & Accurate Buy Signal Notifications - newser.com
Should I hold or sell Revolution Medicines Inc. Equity Warrant stock in 2025Entry Point & Verified Technical Trade Signals - newser.com
How Revolution Medicines Inc. stock performs in rising dollar environment2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com
What MACD and RSI say about Revolution Medicines Inc. Equity Warrant2025 Price Momentum & Weekly Setup with ROI Potential - newser.com
Using Bollinger Bands to evaluate Revolution Medicines Inc. Equity WarrantQuarterly Portfolio Review & Risk Managed Investment Strategies - newser.com
What makes Revolution Medicines Inc. (42Z) stock appealing to growth investors2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Is Revolution Medicines Inc. Equity Warrant stock a buy on dips2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
Revolution Medicines Inc. stock trend outlook and recovery pathDividend Hike & Stepwise Trade Execution Plans - newser.com
Is Revolution Medicines Inc. stock a bargain at current levels2025 Analyst Calls & Real-Time Buy Zone Alerts - newser.com
Wolfe Research Initiates Coverage on Revolution Medicines (NASDAQ:RVMD) - MarketBeat
How Revolution Medicines Inc. (42Z) stock reacts to weak economy2025 Market Trends & Risk Adjusted Swing Trade Ideas - newser.com
Revolution Medicines (NASDAQ:RVMD) Sets New 12-Month HighHere's Why - MarketBeat
Why Revolution Medicines Inc. (42Z) stock is a strong analyst pickTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
What institutional flow reveals about Revolution Medicines Inc. Equity Warrant2025 Volatility Report & Fast Entry High Yield Tips - newser.com
Is Revolution Medicines Inc. a candidate for recovery playBull Run & Technical Entry and Exit Alerts - newser.com
Is Revolution Medicines Inc. Equity Warrant showing signs of accumulationEarnings Beat & Technical Buy Zone Confirmation - newser.com
What analysts say about Revolution Medicines Inc stockFundamental Stock Analysis & High Yield Investment Tips - earlytimes.in
Is a relief rally coming for Revolution Medicines Inc. holdersCEO Change & Consistent Growth Equity Picks - newser.com
Officer Cislini Files To Sell 13,388 Of Revolution Medicines Inc [RVMD] - TradingView
RVMD: Wolfe Research Initiates Coverage with Outperform Rating a - GuruFocus
Revolution Medicines, Inc. $RVMD Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
How Revolution Medicines Inc. Equity Warrant stock performs in rising dollar environmentWeekly Risk Summary & Weekly Watchlist for Hot Stocks - newser.com
Revolution Medicines is 'within sight' of 1,000 employees and looking for a new office to fit them - The Business Journals
What to expect from Revolution Medicines Inc. Equity Warrant in the next 30 daysTrade Analysis Summary & Safe Entry Trade Reports - newser.com
Revolution Medicines Advances RAS(ON) Inhibitors in NSCLC Study - MSN
Revolution Medicines, Inc. $RVMD Shares Sold by Bank of New York Mellon Corp - MarketBeat
Revolution Medicines Insider Sold Shares Worth $1,301,410, According to a Recent SEC Filing - MarketScreener
Revolution Medicines Inc (RVMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):